Tokyo, Nov. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059605) titled 'Pharmacokinetic Evaluation of Bioactive Components in a Test Substance Administered to Healthy Adults' on Nov. 1.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponsor:
Institute - Otsuka Pharmaceutical Co., Ltd.
Condition:
Condition - Healthy volunteer
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the pharmacokinetics of the constituent compounds contained in the test substance following its administration to healthy adult subjects....